Skip to content
OpenCapital
Get started

Cumberland Pharmaceuticals CPIX EV / sales

EV / sales at other companies

Baxter International logo
Baxter InternationalBAX
0.6×-0.8×
PTH
Pelthos Therapeutics Inc.PTHS
2.5×—
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
1.8×+0.4×
BridgeBio Pharma logo
BridgeBio PharmaBBIO
28.9×-18.5×
RFL
Rafael Holdings, Inc.RFL
96.4×-30.9×
Opko Health logo
Opko HealthOPK
1.6×-0.1×

Other financials

Income statement

See full
Revenue$9.1M-22.0%
Gross profit$7.2M-30.0%
Operating income-$3.1M-342%
Net income-$3.3M-362%
EPS (diluted)-$0.22-375%

Balance sheet

See full
Cash & equivalents$11.0M-27.1%
Total debt$4.8M-7.1%
Total equity$21.6M-24.5%
Total assets$71.0M+1.5%

Cash flow

See full
Operating cash flow$387.0K-90.1%
CapEx--100%
Free cash flow$387.0K-89.9%

Valuation

See full
Market cap$97.09M+142%
Enterprise value$90.91M+212%
P/S2.3×+1.4×

Profitability

See full
Gross margin82.9%-1.4pp
Operating margin-17.2%-125pp
Net margin-17.6%-103pp
FCF margin3.3%—

Returns & leverage

See full
Return on equity-29.4%-86.3pp
Debt / equity0.2×0.0×
Current ratio1×-0.3×

Where this comes from

Calculated from Cumberland Pharmaceuticals’s reported figures.

enterprise value/total revenue=1×

Based on the most recent quarter.

The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cumberland Pharmaceuticals's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cumberland Pharmaceuticals's EV / sales?
Cumberland Pharmaceuticals (CPIX) reported EV / sales of 1× in Q1 2026.
How has Cumberland Pharmaceuticals's EV / sales changed year-over-year?
Cumberland Pharmaceuticals's EV / sales decreased by 15.5% year-over-year, from 1.2× to 1×.
What is the long-term trend for Cumberland Pharmaceuticals's EV / sales?
Over 5 years (2020 to 2025), Cumberland Pharmaceuticals's EV / sales has grown at a 15.7% compound annual growth rate (CAGR), from 0.6× to 1.2×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.